37
Views
6
CrossRef citations to date
0
Altmetric
Review Article

HIV prevalence among IDUs in Australia: a methodological review

, , , &
Pages 175-184 | Published online: 12 Jul 2009

References

  • Friedman SR, Des Jarlais DC. HIV among drug injectors: the epidemic and the response. AIDS Care 1991; 3: 239–250
  • Naik TN, Sarkar S, Singh HL, Bhunia SC, Singh YI, Singh PK, Pal SC. Intravenous drug users—new high-risk group for infection in India. AIDS 1991; 5: 117–118
  • Des Jarlais, DC, Friedman, SR, Novick, DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. J Am Med Ass 1989; 292: 527–530
  • Centers for Disease Control. HIV/AIDS Surveillance February 1992. US Department of Health and Human Services. 1992
  • European Centre for the Epidemiological Monitoring of AIDS Quarterly Report No 34. AIDS Surveillance in Europe; European vertically acquired AIDS data set: EVAADS Quarterly Report No. 34 1992; 17–23
  • Denham I, Hayes P. Human immunodeficiency virus antibody testing at the Melbourne sexually transmitted diseases centre 1984–1989. Venereology 1990; 3: 4–13
  • Donovan, B, Finlayson, RJ, Mutimer, K, et al. HIV infection in sexually transmissible disease practice in Sydney: the effects of legislation, public education and changing clinical spectrum. Int J STD and AIDS 1990; 1–1
  • McDonald, AM, Whyte, BM, Jacobs, D, et al. Voluntary HIV antibody testing among STD clinic patients: a pilot study. Med J Aust 1990; 153: 12–14
  • Morlet A, Darke S, Guinan JJ, Wolk J, Gold J. Intravenous drug users who present to the Albion Street (AIDS) Centre for diagnosis and management of human immunodeficiency virus infection. Med J Aust 1990; 152: 78–80
  • Kelly H, Sesnan K, Keith K, Machin J. Sentinel testing for the human immunodeficiency virus antibody at the Murray Street clinic, Perth, Western Australia. 1991, Unpublished report
  • Blacker P, Wodak A, Tindall B, Cooper D. Exposure of intravenous drug users to AIDS retrovirus, Sydney, 1985. Aust NZ J Med 1986; 16: 686–690
  • Dwyer, D, Bell, J, Batey, R, et al. Low prevalence of human immunodeficiency virus infection in methadone program attenders and pregnant intravenous drug users in the Western Metropolitan Region of Sydney. Aust NZ J Med 1989; 19: 407–408
  • Bell J, Fernandes D, Batey R. Heroin users seeking methadone treatment. Med J Aust 1990; 152: 361–364
  • Wolk J, Wodak A, Morlet A, Guinan JJ, Gold J. HIV-related risk-taking behaviour, knowledege and serostatus of intravenous drug users in Sydney. Med J Aust 1990; 152: 453–458
  • Buckley R, van Beek I, Roach A, Kaldor JM. Patterns of HIV prevalence among injecting drug users seeking primary health care. Abstract. Australian Society of HIV Medicine 3rd Annual Conference on Medical and Scientific Aspects of HIV/AIDS. Wollongong 1991
  • McLaws M-L, McGirr J, Croker W, Cooper DA. Risk of human immunodeficiency and hepatitis B viral infections in intravenous drug abusers. Med J Aust 1988; 148: 263–265
  • Reid C, Kaldor J, Lord R, Cooper DA. HIV risk factors and seroprevalence in surgical patients. Med J Aust 1993; 158: 21–23
  • Kaldor, JM, Archer, GT, Buring, ML, et al. Risk factors for hepatitis C virus infection in blood donors: A case-control study. Med J Aust 1992; 157: 227–230
  • Australian National AIDS and injecting drug use study. Neither a borrower nor a lender be: First report of the Australian national AIDS and injecting drug use study, 1989 data collection. ANAIDUS. 1991
  • Australian National AIDS and Injecting Drug Use Study. Not in a Fit: Third Report of the Australian National AIDS and Injecting Drug Use Study. 1992
  • Loxley WM, Marsh AM, Hawks DV, Quigley AJ. HIV risk behaviour among injecting drug users in Perth. The Australian National AIDS and Injecting Drug Use Study. Med J Aust 1992; 156: 687–687
  • National Centre in HIV Epidemiology and Clinical Research. Australian HIV Surveillance Report 1992; 8(Supplement 3)
  • Crofts N, Hay M. Entry of human immunodeficiency virus infection into a population of injecting drug users, Victoria, 1990. Med J Aust 1991; 155: 378–382
  • Turnbull PJ, Stimson GV, Dolan KA. Prevalence of HIV infection among ex-prisoners in England. BMJ 1992; 304(6823)381–382
  • Crofts N, Nicholson S, Coghlen P, Gust ID. Testing of saliva for antibodies to HIV-1. AIDS 1991; 5: 561–563
  • Ball JC. The reliability and validity of interview data obtained from 59 narcotic drug addicts. Am J Socio 1967; 72: 650–654
  • Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1991; 87: 733–742
  • Darke S, Heather N, Hall W, Ward J, Wodak A. Estimating drug consumption in opioid users: reliability and validity of a ‘recent use’ episodes method. Br J Addict 1991; 86: 1311–1316
  • McCusker J, Stoddard AM, McCarthy E. The validity of self-reported HIV antibody test results. Am J Pub Hlth 1992; 82: 567–569
  • Zaccarelli, M, Rezza, G, Girardi, E, et al. Monitoring HIV trends in injecting drug users: an Italian experience. AIDS 1990; 4: 1007–1010
  • Bell, J, Batey, RG, Farrell, GC, et al. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 274–276
  • Fairley CK, Leslie DE, Nicholson S, Gust ID. Epidemiology of hepatitis C virus in Victoria. Med J Aust 1990; 3(5)271–273, 153
  • National HIV/AIDS Strategy. Australian Government Publishing Service, Canberra 1989

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.